Low prevalence of anti-DFS70/LEDGF antibodies in patients with dermatomyositis and other systemic autoimmune rheumatic diseases

Journal of Rheumatology

Volumn 40, Issue 1, 2013, Pages 92-93

  Muro, Yoshinao ^a   Sugiura, Kazumitsu ^a   Nakashima, Ran ^b   Mimori, Tsuneyo ^b   Akiyama, Masashi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; DENSE FINE SPECKLED 70 AUTOANTIBODY; EJ ANTIBODY; JO 1 ANTIBODY; KS ANTIBODY; LENS EPITHELIUM DERIVED GROWTH FACTOR; MDA5 ANTIBODY; MI 2 AUTOANTIBODY; NXP2 ANTIBODY; PL12 ANTIBODY; PL7 ANTIBODY; RECOMBINANT PROTEIN; TIF1 ALPHA ANTIBODY; TIF1 GAMMA ANTIBODY; TRANSFER RNA LIGASE ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; AMYOPATHIC DERMATOMYOSITIS; ANTIBODY DETECTION; ANTIBODY TITER; AUTOIMMUNE DISEASE; BLOOD SAMPLING; CANCER ASSOCIATED DERMATOMYOSITIS; CELL LABELING; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; DERMATOMYOSITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; IN VITRO STUDY; INTERSTITIAL LUNG DISEASE; JAPANESE; JUVENILE DERMATOMYOSITIS; LETTER; MALE; ONSET AGE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; RHEUMATIC DISEASE; SCHOOL CHILD; SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIBODIES, ANTI-IDIOTYPIC; AUTOIMMUNE DISEASES; FEMALE; HUMANS; MALE; RHEUMATIC DISEASES; TRANSCRIPTION FACTORS;

EID: 84871898254     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.121168     Document Type: Letter

References (8)

1. Mahler M, Parker T, Peebles CL, Andrade LE, Swart A, Carbonne Y, et al. Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases. J Rheumatol 2012;39:2104-10.
2. Watanabe A, Kodera M, Sugiura K, Usuda T, Tan EM, Takasaki Y, et al. Anti-DFS70 antibodies in 597 healthy hospital workers. Arthritis Rheum 2004;50:892-900. (Pubitemid 38326190)
3. Muro Y, Ishikawa A, Sugiura K, Akiyama M. Clinical features of anti-TIF1-α antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-γ or anti-Mi-2 autoantibodies. Rheumatology 2012;51:1508-13.
4. Ishikawa A, Muro Y, Sugiura K, Akiyama M. Development of an ELISA for detection of autoantibodies to nuclear matrix protein 2. Rheumatology 2012;51:1181-7.
5. Muro Y, Sugiura K, Hoshino K, Akiyama M. Disappearance of anti-MDA-5 autoantibodies in clinically amyopathic DM/interstitial lung disease during disease remission. Rheumatology 2012;51:800-4.
6. Gono T, Kawaguchi Y, Satoh T, Kuwana M, Katsumata Y, Takagi K, et al. Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. Rheumatology 2010;49:1713-9.
7. Shoenfeld Y, Toubi E. Protective autoantibodies: role in homeostasis, clinical importance, and therapeutic potential. Arthritis Rheum 2005;52:2599-606. (Pubitemid 41369087)
8. Goto N, Sugiura K, Ogawa Y, Watanabe A, Onouchi H, Tomita Y, et al. Anti-p80 coilin autoantibodies react with a conserved epitope and are associated with anti-DFS70/LEDGF autoantibodies. J Autoimmun 2006;26:42-51. (Pubitemid 43138892)